11 min readRTB2 Editorial TeamUpdated April 2026

End-Tidal CO₂ Monitoring for Respiratory Therapists

Waveform capnography, airway confirmation, ventilation trending, CPR monitoring, and common clinical patterns — a practical reference for RT practice.

For educational and informational reference only. This content does not constitute medical advice, does not establish a standard of care, and should not replace physician orders, licensed clinical judgment, or institutional policy. Clinical decisions must be made by qualified healthcare professionals using patient-specific assessment.

See also: RTB2 Medical Disclaimer · Editorial Policy

What Is End-Tidal CO₂?

End-tidal CO₂ (ETCO₂) is the partial pressure of carbon dioxide measured at the end of a normal exhalation — representing the peak CO₂ concentration in exhaled gas before the next inhalation dilutes it. Capnography is the continuous, waveform-based measurement of CO₂ throughout the respiratory cycle; capnometry refers to the numeric value alone.

Normal ETCO₂ in a spontaneously breathing adult is approximately 35–45 mmHg, closely tracking (though slightly lower than) arterial PaCO₂ due to dilution by dead space gas. The difference between PaCO₂ and ETCO₂ (the PaCO₂–ETCO₂ gradient) reflects dead space ventilation and is normally 2–5 mmHg. A widened gradient indicates increased dead space (PE, decreased cardiac output, ARDS) or sampling issues.

For respiratory therapists, ETCO₂ monitoring serves several distinct clinical purposes: confirming airway placement, continuously monitoring ventilation trends, guiding CPR quality assessment, and detecting physiologic changes in ventilation-perfusion matching.

The Capnography Waveform (Capnogram)

A normal capnogram has a characteristic four-phase waveform:

Phase I (Baseline) (CO₂ = 0): Dead space gas from the anatomic conducting airways — this gas participates in ventilation of the large airways but not alveolar gas exchange. CO₂ is essentially absent.
Phase II (Upstroke) (Rapid rise): Mixing of dead space gas with alveolar gas — CO₂ rises sharply as alveolar gas reaches the sampling point. A steep, rapid upstroke is normal.
Phase III (Plateau) (Alveolar plateau): Predominantly alveolar gas — CO₂ continues to rise slowly toward its peak. In a normal patient, this plateau is nearly horizontal. The peak at end-exhalation is the ETCO₂ value.
Phase IV (Downstroke) (Rapid fall): Inspiration begins — fresh gas rapidly dilutes CO₂ back toward zero. A nearly vertical descent is normal.

Airway Placement Confirmation

Continuous waveform capnography is the most reliable real-time method for confirming endotracheal tube placement in the trachea. Current advanced life support guidelines and airway management standards recommend capnography as a primary confirmation method following intubation.

Tracheal placement: Consistent CO₂ waveforms with each ventilation cycle confirm that gas exchange is occurring in the lungs. A sustained waveform across multiple breaths — typically 6 consecutive breaths — provides high confidence of tracheal placement.

Esophageal intubation: May initially produce a brief CO₂ waveform from gastric CO₂, but this rapidly extinguishes within 4–6 breaths. Persistent absence of CO₂ or rapidly diminishing waveforms should prompt immediate reassessment of tube position by laryngoscopy.

Important limitation: In patients with very low cardiac output (cardiac arrest, severe circulatory shock), CO₂ delivery to the lungs may be insufficient to produce detectable ETCO₂ even with correct tracheal placement. In cardiac arrest, a low or absent ETCO₂ value does not reliably exclude correct tube placement.

Continuous Ventilation Monitoring

In mechanically ventilated patients, ETCO₂ provides continuous, breath-by-breath feedback on alveolar ventilation — supplementing periodic ABG results with real-time trending.

Rising ETCO₂ indicates increasing CO₂ accumulation — hypoventilation, increasing CO₂ production (fever, sepsis, increased metabolic rate), or increasing dead space. In a patient on controlled ventilation, rising ETCO₂ without a change in ventilator settings should prompt clinical reassessment and may indicate a need for ABG analysis.

Falling ETCO₂ may reflect hyperventilation, decreasing CO₂ production (sedation, hypothermia), improving cardiac output (after resuscitation), or increasing dead space (PE, decreased perfusion).

A sudden drop to near-zero in a mechanically ventilated patient is a critical alarm: possible circuit disconnect, endotracheal tube displacement, cardiac arrest, or massive PE with near-absent pulmonary perfusion.

ETCO₂ During CPR

Capnography has become a standard monitoring tool during cardiac arrest resuscitation. ETCO₂ during CPR reflects pulmonary blood flow — which depends entirely on the quality of chest compressions. Higher ETCO₂ values during CPR (generally >10–15 mmHg) correlate with better quality compressions and improved survival probability.

Uses of ETCO₂ during cardiac arrest:

  • CPR quality feedback: A sudden rise in ETCO₂ during CPR (to >40 mmHg) is a sensitive early indicator of return of spontaneous circulation (ROSC).
  • Prognostication: Persistent ETCO₂ values below 10 mmHg after 20 minutes of resuscitation are associated with very low survival probability — though this must be integrated with clinical context.
  • Tube confirmation: Continuous waveform confirms the airway remains in the trachea throughout the resuscitation effort.

Common Waveform Abnormalities

Shark fin / slanted upstroke (obstructive pattern)

Slow, slanted rise in Phase II with a prolonged, upward-sloping Phase III plateau — characteristic of obstructive airway disease (asthma, COPD, bronchospasm). The upsloping plateau reflects delayed and uneven alveolar emptying across lung units with different time constants.

Curare cleft (notch in plateau)

A notch in the Phase III plateau that occurs when the patient attempts a spontaneous breath against controlled ventilation — commonly seen with inadequate sedation or neuromuscular blockade reversal. The patient's diaphragmatic effort transiently drops ETCO₂ mid-exhalation.

Prolonged plateau with gradual rise

Progressive upsloping Phase III plateau suggests worsening V/Q mismatch or auto-PEEP. Can be seen in evolving bronchospasm, secretion accumulation, or dynamic hyperinflation.

Sudden loss of waveform (flatline)

Complete loss of CO₂ signal: circuit disconnect, cuff failure with massive leak, tube displacement, cardiac arrest, or capnograph sampling failure. Treat as a critical event — immediately assess the patient and circuit.

Elevated baseline

CO₂ not returning to zero between breaths: rebreathing of exhaled gas. Causes include exhausted CO₂ absorber (circle system), inadequate fresh gas flow, or malfunctioning HME.

Low Perfusion States and ETCO₂ Limitations

ETCO₂ depends on CO₂ delivery from the tissues to the lungs via the pulmonary circulation. In states of severe low perfusion — cardiac arrest, profound shock, massive PE, or severe hemorrhage — CO₂ transport to the alveoli is dramatically reduced, causing ETCO₂ to fall independently of ventilation status.

Clinical implications:

  • A low ETCO₂ in a hypotensive patient may reflect circulatory failure rather than hypoventilation.
  • The PaCO₂–ETCO₂ gradient increases significantly in low perfusion states — ETCO₂ underestimates true PaCO₂.
  • In massive PE, ETCO₂ may fall precipitously while PaCO₂ rises — producing an extreme gradient and falsely low ETCO₂.
  • Never titrate ventilator settings based on ETCO₂ alone without correlating with ABG in hemodynamically unstable patients.